The DOI matches its Crossref record; 214 of the 214 references it cites were found in a registry or an index.
Inflammation and immunity in IPF pathogenesis and treatment
Open accessAbstract
Idiopathic pulmonary fibrosis (IPF) is a progressive, and ultimately fatal, chronic interstitial lung disease characterized by enhanced extracellular matrix deposition. Repetitive alveolar epithelial injury triggers the early development of fibrosis. These injuries, in combination with dysregulated wound repair and fibroblast dysfunction, lead to ongoing tissue remodelling and fibrosis seen in end-stage pulmonary fibrosis. Although the exact etiology in IPF is unknown and probably diverse, all stages of fibrosis are accompanied by innate and adaptive immune responses. The role of inflammation as an important component in IPF etiology is controversial and sometimes seen as an epiphenomenon of fibrosis. This view is partly the result of negative multicenter trials of anti-inflammatory drugs for IPF treatment. However, new insights on the role of macrophages, the loss of T-cell and B-cell tolerance leading auto-immune responses in IPF, and the interaction of immune cells with (myo)fibroblasts have led to a slow change of this opinion. Clearly, more insight is needed to integrate basic immune mechanisms into translational research and finally new IPF therapies. In this concise review, we will focus on the role of our innate and adaptive immune system in the initiation and perpetuation of IPF pathobiology. Next, we will discuss how immune responses are influenced by current anti-fibrotic treatments, such as pirfenidone and nintedanib and end with an overview of recent and upcoming therapeutic trials that target and modulate our immune system in patients with IPF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2009-040gl · Cited by 7,186
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
Monocyte and macrophage heterogeneity
Gordon, S., & Taylor, P. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1733 · Cited by 5,190
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873
Macrophage biology in development, homeostasis and disease
Wynn, T. A., Chawla, A., & Pollard, J. W. (2013) · Nature · doi:10.1038/nature12034 · Cited by 4,684
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Richeldi, L., du Bois, R. M., Raghu, G., Azuma, A., Brown, K. K., Costabel, U., Cottin, V., Flaherty, K. R., Hansell, D. M., Inoue, Y., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402584 · Cited by 4,654
Cellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
Alternative activation of macrophages: mechanism and functions
Gordon, S., & Martinez, F. O. (2010) · Immunity · doi:10.1016/j.immuni.2010.05.007 · Cited by 4,197
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
King, T. E., Bradford, W. Z., Castro-Bernardini, S., Fagan, E. A., Glaspole, I., Glassberg, M. K., Gorina, E., Hopkins, P. M., Kardatzke, D., Lancaster, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402582 · Cited by 3,975
Monocyte Chemoattractant Protein-1 (MCP-1): An Overview
Deshmane, S. L., Kremlev, S., Amini, S., & Sawaya, B. E. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2008.0027 · Cited by 3,889
Vignali, D. A. A., Collison, L. W., & Workman, C. J. (2008) · Nature Reviews Immunology · doi:10.1038/nri2343 · Cited by 3,463
The role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623
Interleukin-17 Family Members and Inflammation
Kolls, J. K., & Lindén, A. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.018 · Cited by 2,372
Merad, M., Sathe, P., Helft, J., Miller, J., & Mortha, A. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-074950 · Cited by 2,309
Raghu, G., Rochwerg, B., Zhang, Y., Garcia, C. A. C., Azuma, A., Behr, J., Brozek, J. L., Collard, H. R., Cunningham, W., Homma, S., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201506-1063st · Cited by 1,916
Phenotypic and functional features of human Th17 cells
Annunziato, F., Cosmi, L., Santarlasci, V., Maggi, L., Liotta, F., Mazzinghi, B., Parente, E., Filì, L., Ferri, S., Frosali, F., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070663 · Cited by 1,861
Monocytes and macrophages: developmental pathways and tissue homeostasis
Ginhoux, F., & Jung, S. (2014) · Nature Reviews Immunology · doi:10.1038/nri3671 · Cited by 1,840
Fibrotic disease and the TH1/TH2 paradigm
Wynn, T. A. (2004) · Nature Reviews Immunology · doi:10.1038/nri1412 · Cited by 1,765
Prednisone, Azathioprine, and N -Acetylcysteine for Pulmonary Fibrosis
The Idiopathic Pulmonary Fibrosis Clinical Research Network (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113354 · Cited by 1,621
The multifaceted functions of neutrophils
Mayadas, T. N., Cullere, X., & Lowell, C. A. (2014) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020712-164023 · Cited by 1,356
Circulating Fibrocytes Define a New Leukocyte Subpopulation That Mediates Tissue Repair
Bucala, R., Spiegel, L. A., Chesney, J., Hogan, M., & Cerami, A. (1994) · Molecular Medicine · doi:10.1007/bf03403533 · Cited by 1,308
Integrating mechanisms of pulmonary fibrosis
Wynn, T. A. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110551 · Cited by 1,274
M1 and M2 Macrophages: Oracles of Health and Disease
Mills, C. (2012) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v32.i6.10 · Cited by 1,141
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis
Phillips, R. J., Burdick, M. D., Hong, K., Lutz, M. A., Murray, L. A., Xue, Y. Y., Belperio, J. A., Keane, M. P., & Strieter, R. M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420997 · Cited by 1,079
Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis
Wollin, L., Wex, E., Pautsch, A., Schnapp, G., Hostettler, K. E., Stowasser, S., & Kolb, M. (2015) · European Respiratory Journal · doi:10.1183/09031936.00174914 · Cited by 1,005
Lee, C. G., Homer, R. J., Zhu, Z., Lanone, S., Wang, X., Koteliansky, V., Shipley, J. M., Gotwals, P., Noble, P., Chen, Q., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.809 · Cited by 940
Mast cell-orchestrated immunity to pathogens
Abraham, S. N., & St. John, A. L. (2010) · Nature Reviews Immunology · doi:10.1038/nri2782 · Cited by 837
Pulmonary fibrosis: pathogenesis, etiology and regulation
Wilson, M. S., & Wynn, T. A. (2009) · Mucosal Immunology · doi:10.1038/mi.2008.85 · Cited by 822
T-cell subsets (Th1 versus Th2)
Romagnani, S. (2000) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)62426-x · Cited by 815
Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis
Fingerlin, T. E., Murphy, E., Zhang, W., Peljto, A. L., Brown, K. K., Steele, M. P., Loyd, J. E., Cosgrove, G. P., Lynch, D., Groshong, S., et al. (2013) · Nature Genetics · doi:10.1038/ng.2609 · Cited by 809
Short telomeres are a risk factor for idiopathic pulmonary fibrosis
Alder, J. K., Chen, J. J.-L., Lancaster, L., Danoff, S., Su, S.-C., Cogan, J. D., Vulto, I., Xie, M., Qi, X., Tuder, R. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804280105 · Cited by 805
The regulation of IgA class switching
Cerutti, A. (2008) · Nature Reviews Immunology · doi:10.1038/nri2322 · Cited by 756
Thien, M., Phan, T. G., Gardam, S., Amesbury, M., Basten, A., Mackay, F., & Brink, R. (2004) · Immunity · doi:10.1016/j.immuni.2004.05.010 · Cited by 746
Innate Lymphoid Cells: Emerging Insights in Development, Lineage Relationships, and Function
Spits, H., & Cupedo, T. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075053 · Cited by 693
A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis
Raghu, G., Brown, K. K., Bradford, W. Z., Starko, K., Noble, P. W., Schwartz, D. A., & King, T. E. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030511 · Cited by 652
The bioactive phospholipid lysophosphatidic acid is released from activated platelets
Eichholtz, T., Jalink, K., Fahrenfort, I., & Moolenaar, W. H. (1993) · Biochemical Journal · doi:10.1042/bj2910677 · Cited by 645
Neutrophil cell surface receptors and their intracellular signal transduction pathways
Futosi, K., Fodor, S., & Mócsai, A. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.06.034 · Cited by 642
Wollin, L., Maillet, I., Quesniaux, V., Holweg, A., & Ryffel, B. (2014) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.208223 · Cited by 633
TH2 cell development and function
Walker, J. A., & McKenzie, A. N. J. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.118 · Cited by 632
Noth, I., Zhang, Y., Ma, S.-F., Flores, C., Barber, M., Huang, Y., Broderick, S. M., Wade, M. S., Hysi, P., Scuirba, J., et al. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70045-6 · Cited by 614
King, T. E., Albera, C., Bradford, W. Z., Costabel, U., Hormel, P., Lancaster, L., Noble, P. W., Sahn, S. A., Szwarcberg, J., Thomeer, M., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60551-1 · Cited by 531
Circulating fibrocytes: collagen-secreting cells of the peripheral blood
Quan, T. E., Cowper, S., Wu, S.-P., Bockenstedt, L. K., & Bucala, R. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2003.10.005 · Cited by 528
Khalil, N., O'Connor, R. N., Unruh, H. W., Warren, P. W., Flanders, K. C., Kemp, A., Bereznay, O. H., & Greenberg, A. H. (1991) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb/5.2.155 · Cited by 521
MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
Juge, P.-A., Lee, J. S., Ebstein, E., Furukawa, H., Dobrinskikh, E., Gazal, S., Kannengiesser, C., Ottaviani, S., Oka, S., Tohma, S., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1801562 · Cited by 520
Circulating Fibrocytes Are an Indicator of Poor Prognosis in Idiopathic Pulmonary Fibrosis
Moeller, A., Gilpin, S. E., Ask, K., Cox, G., Cook, D., Gauldie, J., Margetts, P. J., Farkas, L., Dobranowski, J., Boylan, C., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200810-1534oc · Cited by 513
Matrix Metalloproteinases as Therapeutic Targets for Idiopathic Pulmonary Fibrosis
Craig, V. J., Zhang, L., Hagood, J. S., & Owen, C. A. (2015) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2015-0020tr · Cited by 507
Randomized Trial of Acetylcysteine in Idiopathic Pulmonary Fibrosis
The Idiopathic Pulmonary Fibrosis Clinical Research Network (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401739 · Cited by 505
Interleukin-33-Dependent Innate Lymphoid Cells Mediate Hepatic Fibrosis
Mchedlidze, T., Waldner, M., Zopf, S., Walker, J., Rankin, A. L., Schuchmann, M., Voehringer, D., McKenzie, A. N. J., Neurath, M. F., Pflanz, S., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.07.018 · Cited by 502
A Vicious Circle of Alveolar Macrophages and Fibroblasts Perpetuates Pulmonary Fibrosis via CCL18
Prasse, A., Pechkovsky, D. V., Toews, G. B., Jungraithmayr, W., Kollert, F., Goldmann, T., Vollmer, E., Müller-Quernheim, J., & Zissel, G. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200509-1518oc · Cited by 497
Richeldi, L., Cottin, V., du Bois, R. M., Selman, M., Kimura, T., Bailes, Z., Schlenker-Herceg, R., Stowasser, S., & Brown, K. K. (2016) · Respiratory Medicine · doi:10.1016/j.rmed.2016.02.001 · Cited by 463
The BAFF/APRIL system: Emerging functions beyond B cell biology and autoimmunity
Vincent, F. B., Saulep-Easton, D., Figgett, W. A., Fairfax, K. A., & Mackay, F. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.04.003 · Cited by 445
New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis
Fernandez, I. E., & Eickelberg, O. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61144-1 · Cited by 437
Pilling, D., Fan, T., Huang, D., Kaul, B., & Gomer, R. H. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007475 · Cited by 433
Fibrocytes: emerging effector cells in chronic inflammation
Reilkoff, R. A., Bucala, R., & Herzog, E. L. (2011) · Nature Reviews Immunology · doi:10.1038/nri2990 · Cited by 430
Interstitial lung disease in connective tissue disorders
Fischer, A., & du Bois, R. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61079-4 · Cited by 430
Lech, M., & Anders, H.-J. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.12.001 · Cited by 418
Li, D., Guabiraba, R., Besnard, A.-G., Komai-Koma, M., Jabir, M. S., Zhang, L., Graham, G. J., Kurowska-Stolarska, M., Liew, F. Y., McSharry, C., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.05.011 · Cited by 413
Goswami, R., & Kaplan, M. H. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003049 · Cited by 399
Baylor-Hopkins Center for Mendelian Genomics, Watkin, L. B., Jessen, B., Wiszniewski, W., Vece, T. J., Jan, M., Sha, Y., Thamsen, M., Santos-Cortez, R. L. P., Lee, K., et al. (2015) · Nature Genetics · doi:10.1038/ng.3279 · Cited by 388
The development and in vivo function of T helper 9 cells
Kaplan, M. H., Hufford, M. M., & Olson, M. R. (2015) · Nature Reviews Immunology · doi:10.1038/nri3824 · Cited by 384
IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis
Hams, E., Armstrong, M. E., Barlow, J. L., Saunders, S. P., Schwartz, C., Cooke, G., Fahy, R. J., Crotty, T. B., Hirani, N., Flynn, R. J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315854111 · Cited by 376
GeurtsvanKessel, C. H., Willart, M. A. M., Bergen, I. M., van Rijt, L. S., Muskens, F., Elewaut, D., Osterhaus, A. D. M. E., Hendriks, R., Rimmelzwaan, G. F., & Lambrecht, B. N. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090410 · Cited by 376
Regulated Production of Type I Collagen and Inflammatory Cytokines by Peripheral Blood Fibrocytes
Chesney, J., Metz, C., Stavitsky, A. B., Bacher, M., & Bucala, R. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.1.419 · Cited by 375
Treatment of Idiopathic Pulmonary Fibrosis with Etanercept: An Exploratory, Placebo-controlled Trial
Raghu, G., Brown, K. K., Costabel, U., Cottin, V., du Bois, R. M., Lasky, J. A., Thomeer, M., Utz, J. P., Khandker, R. K., McDermott, L., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200709-1446oc · Cited by 370
Conte, E., Gili, E., Fagone, E., Fruciano, M., Iemmolo, M., & Vancheri, C. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.02.014 · Cited by 368
Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis
Andersson-Sjöland, A., de Alba, C. G., Nihlberg, K., Becerril, C., Ramírez, R., Pardo, A., Westergren-Thorsson, G., & Selman, M. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.02.012 · Cited by 360
CXCL13 is a plasma biomarker of germinal center activity
Havenar-Daughton, C., Lindqvist, M., Heit, A., Wu, J. E., Reiss, S. M., Kendric, K., Bélanger, S., Kasturi, S. P., Landais, E., Akondy, R. S., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520112113 · Cited by 353
Immune mechanisms in pulmonary fibrosis
Kolahian, S., Fernandez, I. E., Eickelberg, O., & Hartl, D. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0121tr · Cited by 349
Wick, G., Grundtman, C., Mayerl, C., Wimpissinger, T.-F., Feichtinger, J., Zelger, B., Sgonc, R., & Wolfram, D. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095937 · Cited by 327
Distinct Differentiation Potential of Blood Monocyte Subsets in the Lung
Landsman, L., Varol, C., & Jung, S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2000 · Cited by 322
A review of the current use of rituximab in autoimmune diseases
Gürcan, H. M., Keskin, D. B., Stern, J. N. H., Nitzberg, M. A., Shekhani, H., & Ahmed, A. R. (2009) · International Immunopharmacology · doi:10.1016/j.intimp.2008.10.004 · Cited by 314
Exploring Animal Models That Resemble Idiopathic Pulmonary Fibrosis
Tashiro, J., Rubio, G. A., Limper, A. H., Williams, K., Elliot, S. J., Ninou, I., Aidinis, V., Tzouvelekis, A., & Glassberg, M. K. (2017) · Frontiers in Medicine · doi:10.3389/fmed.2017.00118 · Cited by 314
Modeling pulmonary fibrosis with bleomycin
Mouratis, M. A., & Aidinis, V. (2011) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e328349ac2b · Cited by 311
Zimmermann, H. W., Seidler, S., Nattermann, J., Gassler, N., Hellerbrand, C., Zernecke, A., Tischendorf, J. J. W., Luedde, T., Weiskirchen, R., Trautwein, C., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011049 · Cited by 310
Gruber, B. L., Kew, R. R., Jelaska, A., Marchese, M. J., Garlick, J., Ren, S., Schwartz, L. B., & Korn, J. H. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.5.2310 · Cited by 309
Toward a Refined Definition of Monocyte Subsets
Ziegler-Heitbrock, L., & Hofer, T. P. J. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00023 · Cited by 298
DePianto, D. J., Chandriani, S., Abbas, A. R., Jia, G., N'Diaye, E. N., Caplazi, P., Kauder, S. E., Biswas, S., Karnik, S. K., Ha, C., et al. (2015) · Thorax · doi:10.1136/thoraxjnl-2013-204596 · Cited by 287
Vermaelen, K., & Pauwels, R. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200410-1384so · Cited by 283
Raghu, G., Brown, K. K., Collard, H. R., Cottin, V., Gibson, K. F., Kaner, R. J., Lederer, D. J., Martinez, F. J., Noble, P. W., Song, J. W., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)30421-0 · Cited by 278
IL-27 Is a Key Regulator of IL-10 and IL-17 Production by Human CD4+ T Cells
Murugaiyan, G., Mittal, A., Lopez-Diego, R., Maier, L. M., Anderson, D. E., & Weiner, H. L. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900568 · Cited by 276
Abnormal lung aging in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis
Faner, R., Rojas, M., MacNee, W., & Agustí, A. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201202-0282pp · Cited by 268
WNT Signaling in Lung Disease: A Failure or a Regeneration Signal?
Königshoff, M., & Eickelberg, O. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0485tr · Cited by 258
Car, B. D., Meloni, F., Luisetti, M., Semenzato, G., Gialdroni-Grassi, G., & Walz, A. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.149.3.8118632 · Cited by 252
Pulmonary Autotaxin Expression Contributes to the Pathogenesis of Pulmonary Fibrosis
Oikonomou, N., Mouratis, M.-A., Tzouvelekis, A., Kaffe, E., Valavanis, C., Vilaras, G., Karameris, A., Prestwich, G. D., Bouros, D., & Aidinis, V. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0004oc · Cited by 250
Mushiroda, T., Wattanapokayakit, S., Takahashi, A., Nukiwa, T., Kudoh, S., Ogura, T., Taniguchi, H., Kubo, M., Kamatani, N., Nakamura, Y., et al. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2008.057356 · Cited by 243
Mathai, S. K., Gulati, M., Peng, X., Russell, T. R., Shaw, A. C., Rubinowitz, A. N., Murray, L. A., Siner, J. M., Antin-Ozerkis, D. E., Montgomery, R. R., et al. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.73 · Cited by 239
IL-33 Mediates Inflammatory Responses in Human Lung Tissue Cells
Yagami, A., Orihara, K., Morita, H., Futamura, K., Hashimoto, N., Matsumoto, K., Saito, H., & Matsuda, A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903818 · Cited by 237
[Interstitial lung disease in connective tissue disorders].
Carmier, D., Diot, É., Guilleminault, L., & Marchand-Adam, S. (2014) · PubMed · Cited by 237
Maher, T. M., van der Aar, E. M., Van de Steen, O., Allamassey, L., Desrivot, J., Dupont, S., Fagard, L., Ford, P., Fieuw, A., & Wuyts, W. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30181-4 · Cited by 231
Global impairment of CD4+CD25+FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis
Kotsianidis, I., Nakou, E., Bouchliou, I., Tzouvelekis, A., Spanoudakis, E., Steiropoulos, P., Sotiriou, I., Aidinis, V., Margaritis, D., Tsatalas, C., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200812-1936oc · Cited by 230
Reduction of Bleomycin-Induced Pulmonary Fibrosis by Serum Amyloid P
Pilling, D., Roife, D., Wang, M., Ronkainen, S. D., Crawford, J. R., Travis, E. L., & Gomer, R. H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.4035 · Cited by 230
Raghu, G., van den Blink, B., Hamblin, M. J., Brown, A. W., Golden, J. A., Ho, L. A., Wijsenbeek, M. S., Vasakova, M., Pesci, A., Antin-Ozerkis, D. E., et al. (2018) · JAMA · doi:10.1001/jama.2018.6129 · Cited by 227
Self-citationCorticosteroids for idiopathic pulmonary fibrosis
Richeldi, L., Davies, H. R. H. R., Spagnolo, P., & Luppi, F. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002880 · Cited by 219
Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters.
Iyer, S. N., Wild, J. S., Schiedt, M. J., Hyde, D. M., Margolin, S. B., & Giri, S. N. (1995) · PubMed · Cited by 217
Neutrophil elastase promotes myofibroblast differentiation in lung fibrosis
Gregory, A. D., Kliment, C. R., Metz, H. E., Kim, K.-H., Kargl, J., Agostini, B. A., Crum, L. T., Oczypok, E. A., Oury, T. A., & Houghton, A. M. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3hi1014-493r · Cited by 216
Nakashima, T., Jinnin, M., Yamane, K., Honda, N., Kajihara, I., Makino, T., Masuguchi, S., Fukushima, S., Okamoto, Y., Hasegawa, M., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1100591 · Cited by 210
Collard, H. R., Yow, E., Richeldi, L., Anstrom, K. J., Glazer, C., & for the IPFnet investigators (2013) · Respiratory Research · doi:10.1186/1465-9921-14-73 · Cited by 207
Macrophage Activation in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Schupp, J. C., Binder, H., Jäger, B., Cillis, G., Zissel, G., Müller-Quernheim, J., & Prasse, A. (2015) · PLOS ONE · doi:10.1371/journal.pone.0116775 · Cited by 204
Palmer, S. M., Snyder, L., Todd, J. L., Soule, B., Christian, R., Anstrom, K., Luo, Y., Gagnon, R., & Rosen, G. (2018) · Chest · doi:10.1016/j.chest.2018.08.1058 · Cited by 202
C-X-C Motif Chemokine 13 (CXCL13) Is a Prognostic Biomarker of Idiopathic Pulmonary Fibrosis
Vuga, L. J., Tedrow, J. R., Pandit, K. V., Tan, J., Kass, D. J., Xue, J., Chandra, D., Leader, J. K., Gibson, K. F., Kaminski, N., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201309-1592oc · Cited by 197
Kahloon, R. A., Xue, J., Bhargava, A., Csizmadia, E., Otterbein, L., Kass, D. J., Bon, J., Soejima, M., Levesque, M. C., Lindell, K. O., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201203-0506oc · Cited by 190
Th17-Polarized Immune Response in a Murine Model of Hypersensitivity Pneumonitis and Lung Fibrosis
Simonian, P. L., Roark, C. L., Wehrmann, F., Lanham, A. K., Diaz del Valle, F., Born, W. K., O’Brien, R. L., & Fontenot, A. P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.657 · Cited by 190
Th9 cells, new players in adaptive immunity
Schmitt, E., Klein, M., & Bopp, T. (2014) · Trends in Immunology · doi:10.1016/j.it.2013.10.004 · Cited by 189
A Novel Antifibrotic Mechanism of Nintedanib and Pirfenidone. Inhibition of Collagen Fibril Assembly
Knüppel, L., Ishikawa, Y., Aichler, M., Heinzelmann, K., Hatz, R., Behr, J., Walch, A., Bächinger, H. P., Eickelberg, O., & Staab-Weijnitz, C. A. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0217oc · Cited by 183
Clinical significance of MCP‐1 levels in BALF and serum in patients with interstitial lung diseases
Suga, M., Iyonaga, K., Ichiyasu, H., Saita, N., Yamasaki, H., & Ando, M. (1999) · European Respiratory Journal · doi:10.1034/j.1399-3003.1999.14b23.x · Cited by 182
Nathan, S. D., Albera, C., Bradford, W. Z., Costabel, U., du Bois, R. M., Fagan, E. A., Fishman, R. S., Glaspole, I., Glassberg, M. K., Glasscock, K. F., et al. (2016) · Thorax · doi:10.1136/thoraxjnl-2015-207011 · Cited by 180
Marchal-Sommé, J., Uzunhan, Y., Marchand-Adam, S., Valeyre, D., Soumelis, V., Crestani, B., & Soler, P. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.10.5735 · Cited by 179
The immunology of fibrosis: innate and adaptive responses
Wick, G., Backovic, A., Rabensteiner, E., Plank, N., Schwentner, C., & Sgonc, R. (2010) · Trends in Immunology · doi:10.1016/j.it.2009.12.001 · Cited by 179
Raghu, G., Scholand, M. B., de Andrade, J., Lancaster, L., Mageto, Y., Goldin, J., Brown, K. K., Flaherty, K. R., Wencel, M., Wanger, J., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.01030-2015 · Cited by 175
Potential action of IL-4 and IL-13 as fibrogenic factors on lung fibroblasts in vitro
Saito, A., Okazaki, H., Sugawara, I., Yamamoto, K., & Takizawa, H. (2003) · International Archives of Allergy and Immunology · doi:10.1159/000073718 · Cited by 167
Plasma B Lymphocyte Stimulator and B Cell Differentiation in Idiopathic Pulmonary Fibrosis Patients
Xue, J., Kass, D. J., Bon, J., Vuga, L., Tan, J., Csizmadia, E., Otterbein, L., Soejima, M., Levesque, M. C., Gibson, K. F., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203476 · Cited by 161
BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia
Veeraraghavan, S., Latsi, P. I., Wells, A. U., Pantelidis, P., Nicholson, A. G., Colby, T. V., Haslam, P. L., Renzoni, E. A., & du Bois, R. M. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00105202 · Cited by 160
CC-chemokine ligand 2 inhibition in idiopathic pulmonary fibrosis: a phase 2 trial of carlumab
Raghu, G., Martínez, F. J., Brown, K. K., Costabel, U., Cottin, V., Wells, A. U., LANCASTER, L. H., Gibson, K. F., Haddad, T., Agarwal, P., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01558-2014 · Cited by 158
Rottoli, P., Magi, B., Perari, M. G., Liberatori, S., Nikiforakis, N., Bargagli, E., Cianti, R., Bini, L., & PALLINI, V. (2005) · PROTEOMICS · doi:10.1002/pmic.200301007 · Cited by 151
Re, S. L., Dumoutier, L., Couillin, I., Vyve, C. V., Yakoub, Y., Uwambayinema, F., Marien, B., van den Brûle, S., Snick, J. V., Uyttenhove, C., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0900459 · Cited by 150
The Effects of the Nude (nu/nu) Mutation on Bleomycin-induced Pulmonary Fibrosis
Schrier, D. J., Phan, S. H., & McGarry, B. M. (1983) · American Review of Respiratory Disease · doi:10.1164/arrd.1983.127.5.614 · Cited by 149
A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis
Moretti, S., Renga, G., Oikonomou, V., Galosi, C., Pariano, M., Iannitti, R. G., Borghi, M., Puccetti, M., Zuani, M. D., Pucillo, C. E. M., et al. (2017) · Nature Communications · doi:10.1038/ncomms14017 · Cited by 148
Zhou, Y., Lee, J., Lee, C.-M., Cho, W., Kang, M., Koff, J. L., Yoon, P.-O., Chae, J., Park, H.-O., Elias, J. A., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.356824 · Cited by 147
IL-12 attenuates bleomycin-induced pulmonary fibrosis
Keane, M. P., Belperio, J. A., Burdick, M. D., & Strieter, R. M. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.281.1.l92 · Cited by 146
Idiopathic pulmonary fibrosis: lessons from clinical trials over the past 25 years
Raghu, G. (2017) · European Respiratory Journal · doi:10.1183/13993003.01209-2017 · Cited by 146
Jones, G. W., & Jones, S. A. (2015) · Immunology · doi:10.1111/imm.12554 · Cited by 146
Braun, R. K., Ferrick, C., Neubauer, P. D., Sjoding, M. W., Sterner‐Kock, A., Kock, M., Putney, L. F., Ferrick, D. A., Hyde, D. M., & Love, R. B. (2008) · Inflammation · doi:10.1007/s10753-008-9062-6 · Cited by 145
An earlier and more confident diagnosis of idiopathic pulmonary fibrosis
du Bois, R. M. (2012) · European Respiratory Review · doi:10.1183/09059180.00000812 · Cited by 145
Anti-Inflammatory Effect of Pirfenidone in the Bleomycin-Hamster Model of Lung Inflammation
Iyer, S. N., Hyde, D. M., & Giri, S. N. (2000) · Inflammation · doi:10.1023/a:1007068313370 · Cited by 144
A neutrophil elastase inhibitor prevents bleomycin-induced pulmonary fibrosis in mice
Takemasa, A., Ishii, Y., & Fukuda, T. (2012) · European Respiratory Journal · doi:10.1183/09031936.00127011 · Cited by 140
Lei, L., Zhao, C., Qin, F., He, Z., Wang, X., & Zhong, X.-N. (2016) · PubMed · Cited by 136
Reilkoff, R. A., Peng, H., Murray, L. A., Peng, X., Russell, T., Montgomery, R., Feghali-Bostwick, C., Shaw, A., Homer, R. J., Gulati, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201206-1109oc · Cited by 135
A phase 2 randomized controlled study of tralokinumab in subjects with idiopathic pulmonary fibrosis
Parker, J. M., Glaspole, I. N., Lancaster, L. H., Haddad, T. J., She, D., Roseti, S. L., Fiening, J. P., Grant, E. P., Kell, C. M., & Flaherty, K. R. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201704-0784oc · Cited by 129
Platelet-derived growth factor-producing CD4+ Foxp3+ regulatory T lymphocytes promote lung fibrosis
Lo Re, S., Lecocq, M., Uwambayinema, F., Yakoub, Y., Delos, M., Demoulin, J.-B., Lucas, S., Sparwasser, T., Renauld, J.-C., Lison, D., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201103-0516oc · Cited by 128
Short telomere length in IPF lung associates with fibrotic lesions and predicts survival
Snetselaar, R., van Batenburg, A. A., van Oosterhout, M. F. M., Kazemier, K. M., Roothaan, S. M., Peeters, T., van der Vis, J. J., Goldschmeding, R., Grutters, J. C., & van Moorsel, C. H. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189467 · Cited by 126
Autoantibody-targeted treatments for acute exacerbations of idiopathic pulmonary fibrosis
Donahoe, M., Valentine, V. G., Chien, N., Gibson, K. F., Raval, J. S., Saul, M., Xue, J., Zhang, Y., & Duncan, S. R. (2015) · PLOS ONE · doi:10.1371/journal.pone.0127771 · Cited by 125
Nuovo, G. J., Hagood, J. S., Magro, C. M., Chin, N., Kapil, R., Davis, L., Marsh, C. B., & Folcik, V. A. (2012) · Modern Pathology · doi:10.1038/modpathol.2011.166 · Cited by 123
Schiller, H. B., Mayr, C. H., Leuschner, G., Strunz, M., Staab-Weijnitz, C. A., Preisendörfer, S., Eckes, B., Moinzadeh, P., Krieg, T. M., Schwartz, D. A., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201611-2263oc · Cited by 121
Identification of periplakin as a new target for autoreactivity in idiopathic pulmonary fibrosis
Taillé, C., Grootenboer-Mignot, S., Boursier, C., Michel, L., Debray, M.-P., Fagart, J., Barrientos, L., Mailleux, A., Cigna, N., Tubach, F., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201001-0076oc · Cited by 120
Suga, H., Rennert, R. C., Rodrigues, M., Sorkin, M., Glotzbach, J. P., Januszyk, M., 藤原敏宏, Longaker, M. T., & Gurtner, G. C. (2014) · Stem Cells · doi:10.1002/stem.1648 · Cited by 114
Analysis of pulmonary features and treatment approaches in the COPA syndrome
Tsui, J. L., Estrada, O., Deng, Z., Wang, K. M., Law, C. S., Elicker, B. M., Jones, K. D., Dell, S., Guðmundsson, G., Hansdóttir, S., et al. (2018) · ERJ Open Research · doi:10.1183/23120541.00017-2018 · Cited by 114
Effect of histamine on proliferation of normal human adult lung fibroblasts
Jordana, M., Befus, A. D., Newhouse, M. T., Bienenstock, J., & Gauldie, J. (1988) · Thorax · doi:10.1136/thx.43.7.552 · Cited by 113
Todd, N., Scheraga, Galvin, Iacono, Britt, Luzina, Burke, & Atamas (2013) · Journal of Inflammation Research · doi:10.2147/jir.s40673 · Cited by 113
Wohlfahrt, T., Usherenko, S., Englbrecht, M., Dees, C., Weber, S., Beyer, C., Gelse, K., Distler, O., Schett, G. A., Distler, J. H. W., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-207388 · Cited by 112
Precision medicine: Beyond the inflection point
Hawgood, S., Hook-Barnard, I. G., O’Brien, T. C., & Yamamoto, K. R. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa9970 · Cited by 112
Kurosu, K., Takiguchi, Y., Okada, O., Yumoto, N., Sakao, S., Tada, Y., Kasahara, Y., Tanabe, N., Tatsumi, K., Weiden, M. D., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.756 · Cited by 111
Differential role of regulatory T cells in early and late stages of pulmonary fibrosis
Boveda-Ruiz, D., D’Alessandro-Gabazza, C. N., Toda, M., Takagi, T., Naito, M., Matsushima, Y., Matsumoto, T., Kobayashi, T., Gil-Bernabe, P., Chelakkot-Govindalayathil, A.-L., et al. (2013) · Immunobiology · doi:10.1016/j.imbio.2012.05.020 · Cited by 110
Arras, M., Huaux, F., Vink, A., Delos, M., Coutelier, J., Many, M., Barbarin, V., Renauld, J., & Lison, D. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.24.4.4249 · Cited by 110
Mast Cells: A Pivotal Role in Pulmonary Fibrosis
Veerappan, A., O’Connor, N., Brazin, J. A., Reid, A. C., Jung, A., McGee, D., Summers, B. D., Branch-Elliman, D., Stiles, B. M., Worgall, S., et al. (2013) · DNA and Cell Biology · doi:10.1089/dna.2013.2005 · Cited by 110
Fingerlin, T. E., Zhang, W. E., Yang, I. V., Ainsworth, H. C., Russell, P. H., Blumhagen, R. Z., Schwarz, M. I., Brown, K. M., Steele, M. P., Loyd, J. E., et al. (2016) · BMC Genetics · doi:10.1186/s12863-016-0377-2 · Cited by 109
Iyonaga, K., Takeya, M., Saita, N., Sakamoto, O., Yoshimura, T., Ando, M., & Takahashi, K. (1994) · Human Pathology · doi:10.1016/0046-8177(94)90117-1 · Cited by 108
CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases
Cai, M., Bonella, F., He, X., Sixt, S. U., Sarría, R., Guzman, J., & Costabel, U. (2013) · Respiratory Medicine · doi:10.1016/j.rmed.2013.06.004 · Cited by 106
SAR156597 in idiopathic pulmonary fibrosis: a phase 2 placebo-controlled study (DRI11772)
Raghu, G., Richeldi, L., Crestani, B., Wung, P. K., Bejuit, R., Espéret, C., Antoni, C., & Soubrane, C. (2018) · European Respiratory Journal · doi:10.1183/13993003.01130-2018 · Cited by 105
Iyer, S. N., Margolin, S. B., Hyde, D. M., & Giri, S. N. (1998) · Experimental Lung Research · doi:10.3109/01902149809046058 · Cited by 104
Idiopathic Pulmonary Fibrosis Related to Endothelial Injury and Antiendothelial Cell Antibodies
MAGRO, C. M. J., Waldman, W. J., Knight, D. A., Allen, J. N., Nádasdy, T., Frambach, G. E., Ross, P., & Marsh, C. B. (2006) · Human Immunology · doi:10.1016/j.humimm.2006.02.026 · Cited by 100
Role of Protease-activated Receptor-2 in Idiopathic Pulmonary Fibrosis
Wygrecka, M., Kwapiszewska, G., Jabłońska, E., von Gerlach, S., Henneke, I., Zakrzewicz, D., Günther, A., Preissner, K. T., & Markart, P. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201009-1479oc · Cited by 99
Ando, M., Miyazaki, E., Itô, T., Hiroshige, S., Nureki, S.-I., Ueno, T., Takenaka, R., Fukami, T., & Kumamoto, T. (2010) · Lung · doi:10.1007/s00408-009-9223-x · Cited by 96
BPIFB1 Is a Lung-Specific Autoantigen Associated with Interstitial Lung Disease
Shum, A. K., Alimohammadi, M., Tan, C. L., Cheng, M., Metzger, T. C., Law, C. S., Lwin, W. W., Perheentupa, J., Bour-Jordan, H., Carel, J., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006998 · Cited by 95
A Role for Dendritic Cells in Bleomycin-induced Pulmonary Fibrosis in Mice?
Bantsimba-Malanda, C., Marchal-Sommé, J., Goven, D., Freynet, O., Michel, L., Crestani, B., & Soler, P. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200907-1164oc · Cited by 95
CD4+CD25hiFoxp3+ Cells Exacerbate Bleomycin-Induced Pulmonary Fibrosis
Birjandi, S. Z., Palchevskiy, V., Xue, Y., Nuñez, S., Kern, R. M., Weigt, S. S., Lynch, J. P., Chatila, T. A., & Belperio, J. A. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.03.020 · Cited by 89
Guiot, J., Henket, M., Corhay, J. L., Moermans, C., & Louis, R. E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171344 · Cited by 87
Pirfenidone exerts antifibrotic effects through inhibition of GLI transcription factors
Didiášová, M., Singh, R. K., Wilhelm, J., Kwapiszewska, G., Wujak, L. A., Zakrzewicz, D., Schaefer, L., Markart, P., Seeger, W., Lauth, M., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201600892rr · Cited by 84
Pulmonary fibrosis in the era of stratified medicine
Mathai, S. K., Newton, C. A., Schwartz, D. A., & Garcia, C. K. (2016) · Thorax · doi:10.1136/thoraxjnl-2016-209172 · Cited by 77
Walls, A. F., BENNETT, A. R., Godfrey, R., Holgate, S. T., & Church, M. K. (1991) · Clinical Science · doi:10.1042/cs0810183 · Cited by 76
γδ T Cells Attenuate Bleomycin-Induced Fibrosis through the Production of CXCL10
Pociask, D. A., Chen, K., Choi, S. M., Oury, T. D., Steele, C. H., & Kolls, J. K. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.11.055 · Cited by 75
Chen, Y., Li, C., Weng, D., Song, L., Tang, W., Dai, W., Yu, Y., Liu, F., Zhao, M., Lu, C., et al. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.11.012 · Cited by 75
CD16-positive circulating monocytes and fibrotic manifestations of systemic sclerosis
Lescoat, A., Lecureur, V., Roussel, M., Sunnaram, B. L., Ballerie, A., Coiffier, G., Jouneau, S., Fardel, O., Fest, T., & Jégo, P. (2017) · Clinical Rheumatology · doi:10.1007/s10067-017-3597-6 · Cited by 75
Hou, Z., Ye, Q., Qiu, M., Yu, H., Han, J., & Zeng, H. (2017) · Respiratory Research · doi:10.1186/s12931-017-0653-3 · Cited by 73
de Alba, C. G., Buendía-Roldán, I., Salgado-Aguayo, A. R., Becerril, C., Ramı́rez, R., González, Y., Checa, M., Navarro, C., Ruiz, V., Pardo, A., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201407-1334oc · Cited by 72
Clinical Experience of the Long-term Use of Pirfenidone for Idiopathic Pulmonary Fibrosis
Bando, M., Yamauchi, H., Ogura, T., Taniguchi, H., Watanabe, K., Azuma, A., Homma, S. A., & Sugiyama, Y. (2016) · Internal Medicine · doi:10.2169/internalmedicine.55.5272 · Cited by 72
Duru, N., Wolfson, B., & Zhou, Q. Y. (2016) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v7.i4.231 · Cited by 71
McGaha, T. L., Le, M. N., Kodera, T., Stoica, C., Zhu, J., Paul, W. E., & Bona, C. A. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11089 · Cited by 66
Visner, G. A., Liu, F., Bizargity, P., Liu, H., Liu, K., Yang, J., Wang, L., & Hancock, W. W. (2009) · Transplantation · doi:10.1097/tp.0b013e3181ae3392 · Cited by 66
Dobashi, N., Fujita, J., Murota, M., OHTSUKI, Y., Yamadori, I., Yoshinouchi, T., UEDA, R., Bandoh, S., Kamei, T., Nishioka, M., et al. (2000) · Lung · doi:10.1007/s004080000020 · Cited by 66
Moore, B. B., Fry, C., Zhou, Y., Murray, S., Han, M. K., Martínez, F. J., Flaherty, K. R., & The COMET Investigators (2014) · Frontiers in Medicine · doi:10.3389/fmed.2014.00056 · Cited by 65
Pulmonary CCR2+CD4+T cells are immune regulatory and attenuate lung fibrosis development
Milger, K., Yu, Y., Brudy, E., Irmler, M., Skapenko, A., Mayinger, M. C., Lehmann, M., Beckers, J., Reichenberger, F., Behr, J., et al. (2017) · Thorax · doi:10.1136/thoraxjnl-2016-208423 · Cited by 65
Fibrocytes are increased in lung and peripheral blood of patients with idiopathic pulmonary fibrosis
Heukels, P., van Hulst, J. A. C., van Nimwegen, M., Boorsma, C. E., Melgert, B. N., van den Toorn, L. M., Boomars, K. A., Wijsenbeek, M. S., Hoogsteden, H. C., von der Thüsen, J. H., et al. (2018) · Respiratory Research · doi:10.1186/s12931-018-0798-8 · Cited by 64
Self-citationYANG, Y., FUJITA, J., BANDOH, S., OHTSUKI, Y., YAMADORI, I., YOSHINOUCHI, T., & ISHIDA, T. (2002) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2002.01811.x · Cited by 62
Resolution of bleomycin-induced murine pulmonary fibrosis via a splenic lymphocyte subpopulation
Kamio, K., Azuma, A., Matsuda, K., Usuki, J., Inomata, M., Morinaga, A., Kashiwada, T., Nishijima, N., Itakura, S., Kokuho, N., et al. (2018) · Respiratory Research · doi:10.1186/s12931-018-0783-2 · Cited by 62
Profibrotic Effect of IL-9 Overexpression in a Model of Airway Remodeling
van den Brûle, S., Heymans, J., Havaux, X., Renauld, J., Lison, D., Huaux, F., & Denis, O. (2007) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0397oc · Cited by 60
Akcora, B. Ö., Storm, G., Prakash, J., & Bansal, R. (2017) · Scientific Reports · doi:10.1038/srep44545 · Cited by 60
Jeffery, H. C., McDowell, P., Lutz, P. L., Wawman, R. E., Roberts, S., Bagnall, C., Birtwistle, J., Adams, D., & Oo, Y. H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188649 · Cited by 59
Acute exacerbation of idiopathic pulmonary fibrosis: a clinical review
Luppi, F., Cerri, S., Taddei, S., Ferrara, G., & Cottin, V. (2015) · Internal and Emergency Medicine · doi:10.1007/s11739-015-1204-x · Cited by 56
Chenivesse, C., & Tsicopoulos, A. (2018) · Cytokine · doi:10.1016/j.cyto.2018.01.023 · Cited by 55
Fujiwara, A., Kobayashi, H., Masuya, M., Maruyama, M., Nakamura, S., Ibata, H., Fujimoto, H., Ohnishi, M., Urawa, M., Naito, M., et al. (2012) · Respirology · doi:10.1111/j.1440-1843.2012.02167.x · Cited by 52
Peng, X., Moore, M. W., Peng, H., Sun, H., Gan, Y., Homer, R., & Herzog, E. L. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00080 · Cited by 52
A deleterious role for Th9/IL-9 in hepatic fibrogenesis
Qin, S., Lu, D., Guo, X., Luo, W., Hu, B.-L., Huang, X., Chen, M., Wang, J.-X., Ma, S.-J., Yang, X., et al. (2016) · Scientific Reports · doi:10.1038/srep18694 · Cited by 52
Regulation of group 2 innate lymphoid cells
Duerr, C. U., & Fritz, J. H. (2016) · Cytokine · doi:10.1016/j.cyto.2016.01.018 · Cited by 49
Madala, S. K., Edukulla, R., Schmidt, S., Davidson, C. R., Ikegami, M., & Hardie, W. D. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0042oc · Cited by 46
Inhibitory Effects of Pirfenidone on Dendritic Cells and Lung Allograft Rejection
Bizargity, P., Liu, K., Wang, L., Hancock, W. W., & Visner, G. A. (2012) · Transplantation · doi:10.1097/tp.0b013e3182584879 · Cited by 45
Cox, N., Pilling, D., & Gomer, R. H. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400281 · Cited by 44
Autoantibodies to IL-1 alpha in sera from rapidly progressive idiopathic pulmonary fibrosis.
Ogushi, F., Tani, K., Endo, T., Tada, H., Kawano, T., Asano, T., Huang, L., Ohmoto, Y., Muraguchi, M., Moriguchi, H., et al. (2001) · PubMed · Cited by 43
Dong, Z., Lu, X., Yang, Y., Zhang, T., Li, Y., Chai, Y., Lei, W., Li, C., Ai, L., & Tai, W. (2015) · BMC Pulmonary Medicine · doi:10.1186/s12890-015-0012-4 · Cited by 42
ten Klooster, L., van Moorsel, C. H. M., Erp, J. M. K., van Velzen‐Blad, H., & Grutters, J. C. (2015) · Clinical & Experimental Immunology · doi:10.1111/cei.12636 · Cited by 40
Effect of nintedanib on airway inflammation and remodeling in a murine chronic asthma model
Lee, H. Y., Hur, J., Kim, I. K., Kang, J. Y., Yoon, H. K., Lee, S. Y., Kwon, S. S., Kim, Y. K., & Rhee, C. K. (2017) · Experimental Lung Research · doi:10.1080/01902148.2017.1339141 · Cited by 40
IL-13 signaling via IL-13Rα2 triggers TGF-β1-dependent allograft fibrosis
Brunner, S. M., Schiechl, G., Kesselring, R., Martin, M. P., Balam, S., Schlitt, H. J., Geissler, E. K., & Fichtner‐Feigl, S. (2013) · Transplantation Research · doi:10.1186/2047-1440-2-16 · Cited by 39
Tsoumakidou, M., Karagiannis, K., Bouloukaki, I., Zakynthinos, S. G., Tzanakis, Ν., & Siafakas, N. M. (2009) · Respiration · doi:10.1159/000226244 · Cited by 38
Th1/Th2 Immune Response in Lung Fibroblasts in Interstitial Lung Disease
Sumida, A., Hasegawa, Y., Okamoto, M., Hashimoto, N., Imaizumi, K., Yatsuya, H., Yokoi, T., Takagi, K., Shimokata, K., & Kawabe, T. (2008) · Archives of Medical Research · doi:10.1016/j.arcmed.2008.02.005 · Cited by 38
Navarro‐Partida, J., Martínez-Rizo, A. B., González-Cuevas, J., Arrevillaga-Boni, G., Ortiz-Navarrete, V. F., & Armendáriz‐Borunda, J. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.12.025 · Cited by 37
Targeting interleukin-13 in idiopathic pulmonary fibrosis: from promising path to dead end
Wijsenbeek, M. S., Kool, M., & Cottin, V. (2018) · European Respiratory Journal · doi:10.1183/13993003.02111-2018 · Cited by 35
Self-citationAshitani, J., Mukae, H., Taniguchi, H., Ihi, T., Kadota, J., KOHNO, S., & Matsukura, S. (1999) · Thorax · doi:10.1136/thx.54.11.1015 · Cited by 34
Interleukin-17A antagonist attenuates radiation-induced lung injuries in mice
Wang, B.-Z., Wang, L.-P., Han, H., Cao, F.-L., Li, G.-Y., Xu, J.-L., Wang, X.-W., & Wang, L.-X. (2014) · Experimental Lung Research · doi:10.3109/01902148.2013.872210 · Cited by 33
Dendritic Cell Trafficking and Function in Rare Lung Diseases
Liu, H., Jakubzick, C., Osterburg, A. R., Nelson, R. L., Gupta, N., McCormack, F. X., & Borchers, M. T. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0051ps · Cited by 33
Fu, X., Zhang, D., Li, Y.-D., Zhao, P.-W., Tang, Y., Niu, J., & Li, Y. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000369714 · Cited by 32
IL-9 Protects against Bleomycin-Induced Lung Injury
Arras, M., Louahed, J., Heilier, J.-F., Delos, M., Brombacher, F., Renauld, J., Lison, D., & Huaux, F. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62236-5 · Cited by 30
Cited by
Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis
Moss, B. J., Ryter, S. W., & Rosas, I. O. (2022) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-042320-030240 · Cited by 821
Shared and distinct mechanisms of fibrosis
Distler, J. H. W., Györfi, A.-H., Ramanujam, M., Whitfield, M. L., Königshoff, M., & Lafyatis, R. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0322-7 · Cited by 637
The interplay of fibroblasts, the extracellular matrix, and inflammation in scar formation
Moretti, L., Stalfort, J., Barker, T. H., & Abebayehu, D. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101530 · Cited by 393
Peng, L., Wen, L., Shi, Q.-F., Gao, F., Huang, B., Meng, J., Hu, C.-P., & Wang, C.-M. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-03178-2 · Cited by 385
Idiopathic Pulmonary Fibrosis: An Update on Pathogenesis
Mei, Q., Liu, Z., Zuo, H., Yang, Z., & Qu, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.797292 · Cited by 360
Metadata
- Authors
- Heukels, P., Moor, C. C., von der Thüsen, J. H., Wijsenbeek, M. S., & Kool, M.
- Venue
- Respiratory Medicine
- Publisher
- Elsevier BV
- Published
- 2019-02
- Volume
- 147
- Pages
- 79-91
- ISSN
- 0954-6111 (ISSN-L)
- OpenAlex
- W2909223530
- Cited by
- 517
- References
- 214
- FWCI
- 30.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.